You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 205011 - 205020 of 207712 results
  1. Arterial Cannula with Permissive Distal Perfusion

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A novel cannula design will be developed to provide distal perfusion during arterial cannulation. Arterial cannulation is common in several applications of extracorporeal blood processing. However, placement of a cannula in an artery risks tissue damage due to inadequate perfusion of the artery distal to the cannulation site. A unique solution is presented in t ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  2. Totally Implantable Artificial Lung: Studies for FDA

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): With significant support from the NIH SBIR grant program (5R44HL53168), MC3 has successfully developed an artificial lung, called the BioLung(r). The BioLung(r) design is based on our patented, ultra-low pressure drop artificial lung technology. This device has undergone extensive bench top and animal testing during its development over the past 10 years, an ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  3. Totally Implantable Artificial Lung: Studies for FDA

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): With significant support from the NIH SBIR grant program (5R44HL53168), MC3 has successfully developed an artificial lung, called the BioLung(r). The BioLung(r) design is based on our patented, ultra-low pressure drop artificial lung technology. This device has undergone extensive bench top and animal testing during its development over the past 10 years, an ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  4. Implantable Glucose Sensor with Prolonged Accuracy

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The goal in this study is to fabricate an intravascular glucose sensor that functions accurately for 3 days in vivo. To do this, we will develop an outer membrane that facilitates the conversion of endogenous S- nitrosothiols to nitric oxide locally at the membrane/blood interface. Since nitric oxide is released by the endothelial cells and is responsible for m ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  5. Automatic Control of Extracorporeal Life Support

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    N/A

    SBIR Phase I 1993 Department of Health and Human Services
  6. Totally Implantable Artificial Lung

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    N/A

    SBIR Phase I 1995 Department of Health and Human Services
  7. Vapor-based Manufacturing Multifunctional Coatings

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): We propose a new manufacturing process for multifunctional coatings of biomedical implants. Towards this goal, polymer coatings applied by chemical vapor deposition (CVD) are exceptional candidates for the coating of implanted biomedical devices as indicated by their use in FDA approved drug-eluting stint (Cypher stint, J&J) uses a vapor-deposited polymer (pary ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  8. Impeller optimization for a combined pump-oxygenator

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Lung disease is America's third largest cause of death. Adult respiratory distress syndrome (ARDS) afflicts approximately 150,000 patients every year in the US. Lung disease costs the American economy $148 billion yearly in total expenditures. While treatment for heart disease and cancer has been marked by a significant fall in their rates of death (36.6% for h ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  9. 2D HOLLOW ARRAY SOLID MEMBRANE FOR BLOOD OXYGENATORS

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  10. ANTIPLATELET NITRIC OXIDE RELEASING POLYMER COATINGS

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
US Flag An Official Website of the United States Government